The MarketReader Minute
💊 IBB Drops, Moderna's Decline and Macroeconomic Concerns Weighing on Biotech | Biotech Sector Insights
Among the ETF's holdings, Moderna reported a significant drop in first-quarter revenues, contributing negatively to IBB's performance. Regeneron Pharmaceuticals is set to present new oncology data at the 2025 ASCO Annual Meeting, coinciding with a lowered price target from Guggenheim.